You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
博濟醫藥(300404.SZ):全資子公司獲得一項發明專利證書
格隆匯 07-20 16:38

格隆匯7月20日丨博濟醫藥(300404.SZ)公佈,近日公司全資子公廣州博濟新藥臨牀研究中心有限公司(“新藥有限”)得國家知識產權局頒發的一項發明專利證書,明名稱碎米薺及其提取物在製備預防或治療心律失常藥物中的應用。

該項發明專利為全資子公司新藥有限自主研發的1新藥本發明涉及碎米薺及其提取物在製備預防或治療心律失常的藥物中的應用,屬於生物醫藥技術領域。本發明的碎米薺及其提取物能有效預防或治療心律失常,同時減少室顫發生率和心率失常持續時間,且製備方法科學合理、工藝簡單、可操作性強。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account